Article Information
History
- July 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Himadri Nath1,¶,
- Abinash Mallick1,¶,
- Subrata Roy1,
- Soumi Sukla2,
- Keya Basu3,
- Abhishek De4 and
- Subhajit Biswas1,*
- 1Infectious Diseases and Immunology Division, CSIR- Indian Institute of Chemical Biology, Kolkata, West Bengal, India
- 2National Institute of Pharmaceuticals Education and Research, Kolkata, West Bengal, India
- 3Department of Pathology, Institute of Post-Graduate Medical Education and Research (IPGMER) and Seth Sukhlal Karnani Memorial (SSKM) Hospital, 244, Acharya Jagadish Chandra Bose Road, Kolkata-700020, West Bengal, India
- 4Department of Dermatology, Calcutta National Medical College & Hospital, Kolkata-700014, West Bengal, India
- ↵*Address for correspondence:
Dr. Subhajit Biswas; Email: subhajit.biswas{at}iicb.res.in
↵¶ These authors contributed equally to this work.
Posted July 06, 2020.
Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist
